Juan Hincapie-Castillo

Juan Hincapie-Castillo,

Assistant Professor

Department: Pharmaceutical Outcomes & Policy
Business Phone: (352) 273-5526
Business Email: j.hincapie@ufl.edu

Teaching Profile

Courses Taught
2020-2021
PHA6268 Pharmacoepidemiology and Patient Safety
2020-2021
PHA7979 Advanced Research
2020-2021
PHA6971 Research for Master’s Thesis
2021
PHA6894 Introduction to Graduate Studies
2020-2021
PHA6910 Supervised Research
2019-2021
PHA5244 Prin Evid Based Prac
2020-2021
PHA6935 Selected Topics in Pharmacy
2021
PHA6936 Advanced Topics in Pharmaceutical Sciences
2021
PHA6937 Topics in Pharmaceutical Administration
2020-2021
PHA7980 Research for Doctoral Dissertation
2021
PHA6265 Introduction to Pharmaceutical Outcomes and Policy I
2021
PHA6940 Supervised Teaching
2020
PHA5945 Leadership for International Pharmacy Outreach Experience
2020
PHA5706L Intl Outreach Exper
2018-2019
PHA5226C Pt Safety and Quality
2015
PHA5737 Drugs and Society
2014-2015
PHA5742C Pro Commun Pharm Prac
2014
PHA5226 Evidence-Base Pharmcy

Research Profile

Open Researcher and Contributor ID (ORCID)

Publications

2024
Association between Opioid-Benzodiazepine Trajectories and Injurious Fall Risk among US Medicare Beneficiaries.
Journal of clinical medicine. 13(12) [DOI] 10.3390/jcm13123376. [PMID] 38929905.
2024
Association between trajectories of adherence to endocrine therapy and risk of treated breast cancer recurrence among US nonmetastatic breast cancer survivors.
British journal of cancer. 130(12):1943-1950 [DOI] 10.1038/s41416-024-02680-0. [PMID] 38637603.
2024
Association between trajectories of prescription opioid use and risk of opioid use disorder and overdose among US nonmetastatic breast cancer survivors.
Breast cancer research and treatment. 204(3):561-577 [DOI] 10.1007/s10549-023-07205-6. [PMID] 38191684.
2024
Computational phenotyping within electronic healthcare data to identify transgender people in the United States: A narrative review.
Pharmacoepidemiology and drug safety. 33(3) [DOI] 10.1002/pds.5732. [PMID] 38009550.
2024
Medications for Opioid Use Disorder and Mortality and Hospitalization Among People With Opioid Use-related Infections.
Epidemiology (Cambridge, Mass.). 35(1):7-15 [DOI] 10.1097/EDE.0000000000001681. [PMID] 37820243.
2024
The Unseen Hand: AI-Based Prescribing Decision Support Tools and the Evaluation of Drug Safety and Effectiveness.
Drug safety. 47(2):117-123 [DOI] 10.1007/s40264-023-01376-3. [PMID] 38019365.
2023
Complications in Using Real-World Data to Study the Health of People Who Use Drugs.
Epidemiology (Cambridge, Mass.). 34(2):259-264 [DOI] 10.1097/EDE.0000000000001564. [PMID] 36722808.
2023
Enhancing active learning of medication errors in the PharmD curriculum through a multi-perspective video-based experience.
Currents in pharmacy teaching & learning. 15(3):258-265 [DOI] 10.1016/j.cptl.2023.03.009. [PMID] 37029078.
2023
Mifepristone and the courts: The thread that could unravel regulation of drugs in the United States.
Pharmacoepidemiology and drug safety. 32(9):1049-1051 [DOI] 10.1002/pds.5642. [PMID] 37278192.
2023
Mortality associated with bacterial and fungal infections and overdose among people with drug use diagnoses.
Annals of epidemiology. 87 [DOI] 10.1016/j.annepidem.2023.09.002. [PMID] 37690738.
2023
Patterns of Cough Medication Prescribing among Patients with Chronic Cough in Florida: 2012-2021.
Journal of clinical medicine. 12(19) [DOI] 10.3390/jcm12196286. [PMID] 37834931.
2023
Pragmatic Model and Faculty Toolkit for PharmD Student Engagement in Social and Administrative Pharmacy Research.
American journal of pharmaceutical education. 87(5) [DOI] 10.1016/j.ajpe.2023.02.006. [PMID] 37288693.
2023
Trends in Prescribing of Non-steroidal Anti-inflammatory Medications in the US Ambulatory Care Setting From 2006 to 2016.
The journal of pain. 24(11):1994-2002 [DOI] 10.1016/j.jpain.2023.06.008. [PMID] 37330160.
2023
Trends, characteristics, race, and ethnicity associated with nonadherence to antidepressants among breast cancer survivors with depression.
Journal of managed care & specialty pharmacy. 29(4):431-445 [DOI] 10.18553/jmcp.2023.29.4.431. [PMID] 36989452.
2023
Using Joinpoint regression for drug utilization research: Tutorial and case study of prescription opioid use in the United States.
Pharmacoepidemiology and drug safety. 32(5):509-516 [DOI] 10.1002/pds.5606. [PMID] 36813735.
2022
Buprenorphine Use Trends Following Removal of Prior Authorization Policies for the Treatment of Opioid Use Disorder in 2 State Medicaid Programs.
JAMA health forum. 3(6) [DOI] 10.1001/jamahealthforum.2022.1757. [PMID] 35977240.
2022
Changes in Prescribing by Provider Type Following a State Prescription Opioid Restriction Law.
Journal of general internal medicine. 37(8):1838-1844 [DOI] 10.1007/s11606-021-06966-4. [PMID] 34236602.
2022
Co-utilization of opioids and nonbenzodiazepine hypnotic drugs in U.S. ambulatory care visits, 2006-2016.
Journal of the American Pharmacists Association : JAPhA. 62(2):468-474.e2 [DOI] 10.1016/j.japh.2021.10.020. [PMID] 34799261.
2022
Dosing profiles of concurrent opioid and benzodiazepine use associated with overdose risk among US Medicare beneficiaries: group-based multi-trajectory models.
Addiction (Abingdon, England). 117(7):1982-1997 [DOI] 10.1111/add.15857. [PMID] 35224799.
2022
Environmental scan of COVID-19 infection dashboards in the Florida public school system.
Frontiers in public health. 10 [DOI] 10.3389/fpubh.2022.925808. [PMID] 35968490.
2022
Evaluation of Cough Medication Use Patterns in Ambulatory Care Settings in the United States: 2003-2018.
Journal of clinical medicine. 11(13) [DOI] 10.3390/jcm11133671. [PMID] 35806956.
2022
Medicare Bundled Payment Policy on Anemia Care, Major Adverse Cardiovascular Events, and Mortality among Adults Undergoing Hemodialysis.
Clinical journal of the American Society of Nephrology : CJASN. 17(6):851-860 [DOI] 10.2215/CJN.14361121. [PMID] 35589388.
2022
Prescription Patterns of Adjuvant Pain Medications Following an Opioid Supply Restriction Law: An Interrupted Time Series Analysis.
Medical care. 60(6):432-436 [DOI] 10.1097/MLR.0000000000001719. [PMID] 35315375.
2022
Reducing Health Disparities Through Achieving Pharmacoequity.
JAMA. 327(6):589-590 [DOI] 10.1001/jama.2021.24519. [PMID] 35133419.
2022
Trends in the Management of Headache Disorders in US Emergency Departments: Analysis of 2007-2018 National Hospital Ambulatory Medical Care Survey Data.
Journal of clinical medicine. 11(5) [DOI] 10.3390/jcm11051401. [PMID] 35268492.
2021
A call to look beyond prescription opioid supply-side restrictions and include health equity when predicting opioid policy effectiveness.
Lancet regional health. Americas. 3 [DOI] 10.1016/j.lana.2021.100075. [PMID] 36777402.
2021
A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019.
Medical cannabis and cannabinoids. 4(1):21-42 [DOI] 10.1159/000515069. [PMID] 34676348.
2021
A survey assessment of clinician perceptions of opioid supply and monitoring requirement policy changes.
Journal of opioid management. 17(4):337-342 [DOI] 10.5055/jom.2021.0666. [PMID] 34533828.
2021
Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends.
JAMA internal medicine. 181(6):808-816 [DOI] 10.1001/jamainternmed.2021.1154. [PMID] 33871571.
2021
Changes in Quantity of Opioids Dispensed following Florida’s Restriction Law for Acute Pain Prescriptions.
Pain medicine (Malden, Mass.). 22(8):1870-1876 [DOI] 10.1093/pm/pnab017. [PMID] 33502536.
2021
Changes in Schedule II oral opioid volume dispensed in a private health plan following Florida’s Acute Pain Opioid Restriction Law.
Journal of managed care & specialty pharmacy. 27(6):779-784 [DOI] 10.18553/jmcp.2021.27.6.779. [PMID] 34057389.
2021
Chronic Opioid Therapy Utilization Following an Acute Pain Prescription Supply Restriction Law: An Interrupted Time Series Analysis.
Pain physician. 24(6):417-424 [PMID] 34554682.
2021
Chronic Opioid Therapy: A Scoping Literature Review on Evolving Clinical and Scientific Definitions.
The journal of pain. 22(3):246-262 [DOI] 10.1016/j.jpain.2020.09.002. [PMID] 33031943.
2021
Effects of hydrocodone rescheduling on opioid use outcomes: A systematic review.
Journal of the American Pharmacists Association : JAPhA. 61(2):e20-e44 [DOI] 10.1016/j.japh.2020.09.013. [PMID] 33127312.
2021
Impact of Opioid Restrictions During a Critical Drug Shortage Period: Interrupted Time Series for Institutional Opioid Utilization.
Pain medicine (Malden, Mass.). 22(1):203-211 [DOI] 10.1093/pm/pnaa211. [PMID] 32875327.
2021
Purchasing Drugs Abroad Among U.S. Cancer Survivors: Analysis of the National Health Interview Survey, 2011-2018.
American journal of preventive medicine. 60(5):e231-e234 [DOI] 10.1016/j.amepre.2020.10.017. [PMID] 33358718.
2021
Real-World Fetal Exposure to Acne Treatments in the United States: A Retrospective Analysis from 2006 to 2015.
Drug safety. 44(4):447-454 [DOI] 10.1007/s40264-021-01053-3. [PMID] 33683646.
2021
Trends in Sexually Transmitted Infections in United States Ambulatory Care Clinics from 2005-2016.
Journal of clinical medicine. 11(1) [DOI] 10.3390/jcm11010071. [PMID] 35011812.
2021
Trends in Use of Prescription Nonsteroidal Anti-inflammatory Medications Before vs After Implementation of a Florida Law Restricting Opioid Prescribing for Acute Pain.
JAMA network open. 4(6) [DOI] 10.1001/jamanetworkopen.2021.13383. [PMID] 34115125.
2020
Changes in Opioid Use After Florida’s Restriction Law for Acute Pain Prescriptions.
JAMA network open. 3(2) [DOI] 10.1001/jamanetworkopen.2020.0234. [PMID] 32108887.
2020
Comparative effectiveness of risk mitigation strategies to prevent fetal exposure to mycophenolate.
BMJ quality & safety. 29(8):636-644 [DOI] 10.1136/bmjqs-2019-010098. [PMID] 31649165.
2020
Socioeconomic and Demographic Characteristics of US Adults Who Purchase Prescription Drugs From Other Countries.
JAMA network open. 3(6) [DOI] 10.1001/jamanetworkopen.2020.8968. [PMID] 32579194.
2019
Development of a predictive model for drug-associated QT prolongation in the inpatient setting using electronic health record data.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 76(14):1059-1070 [DOI] 10.1093/ajhp/zxz100. [PMID] 31185072.
2018
Clinical utility and perils of prescription drug monitoring program-based alert systems.
Pain. 159(4):804-805 [DOI] 10.1097/j.pain.0000000000001157. [PMID] 29557901.
2018
Prevalence, Time Trends, and Utilization Patterns of Psychotropic Polypharmacy Among Pediatric Medicaid Beneficiaries, 1999-2010.
Psychiatric services (Washington, D.C.). 69(8):919-926 [DOI] 10.1176/appi.ps.201700260. [PMID] 29879872.
2017
Acute Kidney Injury Risk Associated With Piperacillin/Tazobactam Compared With Cefepime During Vancomycin Therapy in Hospitalised Patients: a Cohort Study Stratified By Baseline Kidney Function
International Journal of Antimicrobial Agents. 50(1):63-67 [DOI] 10.1016/j.ijantimicag.2017.02.023.
2017
Bariatric Surgery and Risk for Perinatal Complications.
JAMA surgery. 152(6):607-608 [DOI] 10.1001/jamasurg.2017.0113. [PMID] 28329328.
2017
Consistency of psychotropic drug-drug interactions listed in drug monographs.
Journal of the American Pharmacists Association : JAPhA. 57(6):698-703.e2 [DOI] 10.1016/j.japh.2017.07.008. [PMID] 28844584.
2017
Development and validation of a complexity score to rank hospitalized patients at risk for preventable adverse drug events.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 74(23):1970-1984 [DOI] 10.2146/ajhp160995. [PMID] 29167139.
2017
Development and validation of a Complexity-Score to rank hospitalized patients at risk for preventable adverse drug events
American Journal of Health-System Pharmacy. 74(23):1970-1984
2017
Evaluating the effects of diffused lavender in an adult day care center for patients with dementia in an effort to decrease behavioral issues: a pilot study.
Journal of drug assessment. 6(1):1-5 [DOI] 10.1080/21556660.2016.1278545. [PMID] 28265482.
2017
Prevalence of Psychotherapy Surrounding Initiation of Psychotropic Polypharmacy in the Medicaid-Insured Population, 1999-2010.
Psychiatric services (Washington, D.C.). 68(11):1120-1126 [DOI] 10.1176/appi.ps.201600511. [PMID] 28669287.
2017
Use of lithium in patients with unipolar depression.
The lancet. Psychiatry. 4(9):662-663 [DOI] 10.1016/S2215-0366(17)30317-6. [PMID] 28853406.
2014
Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain.
P & T : a peer-reviewed journal for formulary management. 39(6):427-35 [PMID] 25050056.
2012
Ototopical neomycin exposure in children with nonintact tympanic membranes.
The Laryngoscope. 122(11):2529-32 [DOI] 10.1002/lary.23554. [PMID] 22965584.

Grants

Jan 2020 – Feb 2021
Leveraging social media data for evaluation of drug use trends after opioid policies
Role: Principal Investigator
Funding: AMER ASSO OF COL OF PHARMACY
Sep 2018 – Jun 2024
University of Florida Resource Center for Minority Aging Research
Role: Project Manager
Funding: NATL INST OF HLTH NIA

Contact Details

Phones:
Business:
(352) 273-5526
Emails:
Business:
j.hincapie@ufl.edu
Addresses:
Business Mailing:
PO Box 100496
GAINESVILLE FL 32610
Business Street:
1225 CENTER DR
HPNP 2338
GAINESVILLE FL 326103007